| Aesthetic Medicine |
1 |
1 |
| Hypertension |
0 |
0.9 |
| Hair |
0 |
0.98 |
| Hair Growth |
0 |
0.99 |
| Alopecia |
0 |
0.23 |
| Patient Safety |
0 |
0.23 |
| Adverse Effects |
0 |
0.21 |
| Antihypertensive Agents |
0 |
0.19 |
| Cosmetic Dermatology |
0 |
0.14 |
| Blood |
0 |
0.11 |
| Edema |
0 |
0.11 |
| Primary Care |
0 |
0.08 |
| Private Practice |
0 |
0.08 |
| Revenue and Practice Management |
0 |
0.08 |
| Heart Failure (HF) |
0 |
0.06 |
| Alopecia Areata |
0 |
0.05 |
| Androgenetic Alopecia |
0 |
0.05 |
| Fluid Retention |
0 |
0.05 |
| Pericardial Effusion |
0 |
0.05 |
| Scar |
0 |
0.05 |
| Telogen Effluvium |
0 |
0.05 |
| Vascular Endothelial Growth Factor |
0 |
0.05 |
| Washington |
0 |
0.05 |
| Arrhythmia |
0 |
0.04 |
| Benign Prostatic Hyperplasia |
0 |
0.04 |
| Coronary Artery Disease (CAD) |
0 |
0.04 |
| Prostate Cancer |
0 |
0.04 |
| Pulmonary Arterial Hypertension |
0 |
0.04 |
| Thyroid Disease |
0 |
0.04 |
| Traction Alopecia |
0 |
0.04 |
| 5-Alpha Reductase Inhibitors |
0 |
0.03 |
| Abdomen |
0 |
0.03 |
| Chemotherapy |
0 |
0.03 |
| Cosmetics |
0 |
0.03 |
| Depression |
0 |
0.03 |
| Dizziness |
0 |
0.03 |
| Face |
0 |
0.03 |
| Headache |
0 |
0.03 |
| Heart |
0 |
0.03 |
| Hypotension |
0 |
0.03 |
| Insomnia |
0 |
0.03 |
| Intravenous |
0 |
0.03 |
| Limb |
0 |
0.03 |
| Match |
0 |
0.03 |
| New York |
0 |
0.03 |
| Nonpharmacologic |
0 |
0.03 |
| Nutrition |
0 |
0.03 |
| Pleural Effusion |
0 |
0.03 |
| Pruritus |
0 |
0.03 |
| PubMed |
0 |
0.03 |
| Pulmonary Hypertension |
0 |
0.03 |
| Sleep Disorders |
0 |
0.03 |
| Suicide |
0 |
0.03 |
| Tachycardia |
0 |
0.03 |
| Thyroid |
0 |
0.03 |
| Traction |
0 |
0.03 |
| Ultrasonography |
0 |
0.03 |
| Vitamin |
0 |
0.03 |